GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:THLD
Delisted

Threshold Pharmaceuticals Fund Forecast

$0.540
+0 (+0%)
At Close: Aug 25, 2017
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

High volatility in Threshold Pharmaceuticals fund price on Friday which ended trading at $0.540
(Updated on Aug 25, 2017)

Buy or Hold candidate since Aug 01, 2017 PDF

No changes to the price of Threshold Pharmaceuticals fund on the last trading day (Friday, 25th Aug 2017). During the last trading day the fund fluctuated 17.02% from a day low at $0.470 to a day high of $0.550. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the fund is expected to rise 28.73% during the next 3 months and, with a 90% probability hold a price between $0.605 and $0.798 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

THLD Signals & Forecast

The Threshold Pharmaceuticals fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.540 and $0.515. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, August 24, 2017, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Support, Risk & Stop-loss for Threshold Pharmaceuticals fund

On the downside, the fund finds support just below today's level from accumulated volume at $0.494 and $0.491. There is a natural risk involved when a fund is testing a support level, since if this is broken, the fund then may fall to the next support level. In this case, Threshold Pharmaceuticals finds support just below today's level at $0.494. If this is broken, then the next support from accumulated volume will be at $0.491 and $0.444.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0.0800 between high and low, or 17.02%. For the last week the fund has had daily average volatility of 17.02%

Our recommended stop-loss: $0.517 (-4.30%) (This fund has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (THLD) For The Upcoming Trading Day Of Monday 28th

For the upcoming trading day on Monday, 28th we expect Threshold Pharmaceuticals to open at $0.520, and during the day (based on 14 day Average True Range), to move between $0.469 and $0.611, which gives a possible trading interval of +/-$0.0707 (+/-13.10%) up or down from last closing price. If Threshold Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 26.20% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.494, some $0.0460 (8.52%) from the current price of $0.540, our system finds the risk reward attractive.

Is Threshold Pharmaceuticals fund A Buy?

Threshold Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.620 Hold/Accumulate Unchanged

Predicted Opening Price for Threshold Pharmaceuticals of Monday, August 28, 2017

Fair opening price August 28, 2017 Current price
$0.520 ( 3.70%) $0.540

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for THLD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.600 11.11 %
R2 0.569 5.45 %
R1 0.551 1.96 %
Current price: 0.540
Support S1 0.489 -9.36 %
S2 0.471 -12.86 %
S3 0.440 -18.52 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.540
Support S1 0.494 -8.52%
S2 0.491 -9.17%
S3 0.444 -17.78%

FAQ

What is the symbol for Threshold Pharmaceuticals Fund and on which exchange is it traded?
The symbol for Threshold Pharmaceuticals is THLD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Threshold Pharmaceuticals Fund?
Threshold Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Threshold Pharmaceuticals Fund?
Threshold Pharmaceuticals Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Threshold Pharmaceuticals Fund.

What's the current price of Threshold Pharmaceuticals Fund?
As of the end of day on the 2017-08-25, the price of an Threshold Pharmaceuticals (THLD) share was $0.540.

What is the 52-week high and low for Threshold Pharmaceuticals Fund?
The 52-week high for Threshold Pharmaceuticals Fund is $1.48 and the 52-week low is $0.350.
Click to get the best stock tips daily for free!

About Threshold Pharmaceuticals

Threshold Pharmaceuticals Threshold Pharmaceuticals, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic agents that target tumor cells for the treatment of patients living with cancer in the United States. Its lead investigational small molecule is evofosfamide, which is in two Phase III clinical trials for the treatment of soft tissue sarcoma indication and advanced pancreatic cancer; Phase II clinical trials for treating non-squamous non-sm... THLD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT